Who invested in Viz

2 rounds we have observed, with the 7 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

AIBiotechHealthcare

Valuation: $1.0B, Oct 2024

Funding summaryUpdated 26 Oct 2026

$7.5Mraised across 2 rounds since 2017, from 2 sources

Latest round: VentureDec 2023
Biggest round: $7.5MSeed · May 2017
Investors: 7

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2017201820192020202120222023

$7.5MSeed?Venture

First round: Seed, $7.5M
Biggest round: $7.5M
Between rounds: 6.5 years

The rounds

Dec 2023
VentureAmount undisclosed5 new
Source recorded
May 2017
Seed$7.5M2 new
- DHVC
- Innovation Endeavors/ AME Cloud
Reported by FinSMEsSEC filing: $4.8M sold, first sale May 2017

Founders and team

From Viz's own website: 1 founder, 8 on the team.

Emily MeltonFounder and Managing Partner

Dawn SpragueVice President of People
Mark LaretPresident & CEO Emeritus
David KiznerGeneral Counsel and Chief Privacy Officer
Jallel HarratiChief Revenue Officer
Mike HerringChief Financial Officer
Steve SweenyChief Business Officer
Mamoon HamidPartner
Rory O'DriscollPartner

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Seed2017Venture2023

DHVCInnovation Endeavors/ AME Cloud

Everyone who backed them

Insight PartnersVC firm1round

SeedcampVC firm1round

Kleiner PerkinsVC firm1round

Pear VCVC firm1round

GreenoaksVC firm1round

DHVCVC firm1round

Innovation Endeavors/ AME Cloudno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Viz as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.